NOVO B — Novo Nordisk A/S Share News
0.000.00%
Last trade - 00:00- DKK1.19tn
- DKK1.28tn
- DKK309.06bn
Brief: Novo Real-World Studies Link Wegovy 2.4 MG To Reductions In Liver Enzymes, Weight, Blood Sugar In Adults With Mash
Lilly to sell obesity drugs directly on Hims & Hers site (updated)
Lilly to sell obesity drugs directly on Hims & Hers site
Brief: Executive Martin Holst Lange Sold Novo Shares Worth DKK 3.4 Mln
Europe Research Roundup: Asos, Erste Group, SCHOTT pharma
Novo loses share in Brazil to cheaper generics, but holds up in Canada and India
European shares rise as Democrats take US Congress, Novo Nordisk surges
Novo Nordisk rises as Q3 Wegovy pill sales, profit beat forecasts
European shares rise as Democratic sweep lifts clean energy, bank stocks
Novo Nordisk seen rising as Wegovy pill, Q3 profit beat forecasts
Novo Nordisk A/S reports results for the quarter ended September 30 - Earnings Summary
Corrected: Novo Nordisk's CFO Karsten Munk Knudsen to leave company
Brief: Novo Nordisk Appoints Luigi La Corte As CFO, Karsten Munk Knudsen Leaves Co
Europe set to open lower as Democratic sweep fuels AI regulation fears
Novo hikes outlook again as it speeds up Wegovy pill rollout (updated)
Brief: Novo Nordisk Q3 Adjusted EBIT At DKK 31,720 Million, Above Estimates
Novo Nordisk Q3 adjusted profit, sales jump on GLP-1 demand; raises outlook
Novo Nordisk Q3 profit beats forecast; raises 2026 guidance
Health Rounds: GLP-1 drugs help control prediabetes better than current standard medicine